142 related articles for article (PubMed ID: 36190971)
41. Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer.
Chen B; Alvarado DM; Iticovici M; Kau NS; Park H; Parikh PJ; Thotala D; Ciorba MA
Cancer Immunol Res; 2020 Apr; 8(4):451-464. PubMed ID: 32127391
[TBL] [Abstract][Full Text] [Related]
42. Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer.
Nguyen DJM; Theodoropoulos G; Li YY; Wu C; Sha W; Feun LG; Lampidis TJ; Savaraj N; Wangpaichitr M
Mol Cancer Res; 2020 Jan; 18(1):105-117. PubMed ID: 31628200
[TBL] [Abstract][Full Text] [Related]
43. IDO Targeting in Sarcoma: Biological and Clinical Implications.
Nafia I; Toulmonde M; Bortolotto D; Chaibi A; Bodet D; Rey C; Velasco V; Larmonier CB; Cerf L; Adam J; Le Loarer F; Savina A; Bessede A; Italiano A
Front Immunol; 2020; 11():274. PubMed ID: 32194552
[TBL] [Abstract][Full Text] [Related]
44. Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients.
Hascitha J; Priya R; Jayavelu S; Dhandapani H; Selvaluxmy G; Sunder Singh S; Rajkumar T
Clin Biochem; 2016 Aug; 49(12):919-24. PubMed ID: 27106797
[TBL] [Abstract][Full Text] [Related]
45. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.
Fujiwara Y; Kato S; Nesline MK; Conroy JM; DePietro P; Pabla S; Kurzrock R
Cancer Treat Rev; 2022 Nov; 110():102461. PubMed ID: 36058143
[TBL] [Abstract][Full Text] [Related]
46. Preparation and evaluation of L- and D-5-[
Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J
Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073
[TBL] [Abstract][Full Text] [Related]
47. 4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth.
Panda S; Pradhan N; Chatterjee S; Morla S; Saha A; Roy A; Kumar S; Bhattacharyya A; Manna D
Sci Rep; 2019 Dec; 9(1):18455. PubMed ID: 31804586
[TBL] [Abstract][Full Text] [Related]
48. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
49. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
[TBL] [Abstract][Full Text] [Related]
50. The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells.
Moreno AC; Clara RO; Coimbra JB; Júlio AR; Albuquerque RC; Oliveira EM; Maria-Engler SS; Campa A
FEBS J; 2013 Oct; 280(19):4782-92. PubMed ID: 23879623
[TBL] [Abstract][Full Text] [Related]
51. Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection.
Majumdar T; Sharma S; Kumar M; Hussain MA; Chauhan N; Kalia I; Sahu AK; Rana VS; Bharti R; Haldar AK; Singh AP; Mazumder S
Cell Death Dis; 2019 Feb; 10(3):161. PubMed ID: 30770800
[TBL] [Abstract][Full Text] [Related]
52. Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
Powderly JD; Klempner SJ; Naing A; Bendell J; Garrido-Laguna I; Catenacci DVT; Taylor MH; Lee JJ; Zheng F; Zhou F; Gong X; Gowda H; Beatty GL
Oncologist; 2022 Nov; 27(11):905-e848. PubMed ID: 36156099
[TBL] [Abstract][Full Text] [Related]
53. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
O'Connor JC; Lawson MA; André C; Moreau M; Lestage J; Castanon N; Kelley KW; Dantzer R
Mol Psychiatry; 2009 May; 14(5):511-22. PubMed ID: 18195714
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy.
Gomes B; Driessens G; Bartlett D; Cai D; Cauwenberghs S; Crosignani S; Dalvie D; Denies S; Dillon CP; Fantin VR; Guo J; Letellier MC; Li W; Maegley K; Marillier R; Miller N; Pirson R; Rabolli V; Ray C; Streiner N; Torti VR; Tsaparikos K; Van den Eynde BJ; Wythes M; Yao LC; Zheng X; Tumang J; Kraus M
Mol Cancer Ther; 2018 Dec; 17(12):2530-2542. PubMed ID: 30232146
[TBL] [Abstract][Full Text] [Related]
55. Prefrontal cortex miR-874-3p prevents lipopolysaccharide-induced depression-like behavior through inhibition of indoleamine 2,3-dioxygenase 1 expression in mice.
Suento WJ; Kunisawa K; Wulaer B; Kosuge A; Iida T; Fujigaki S; Fujigaki H; Yamamoto Y; Tanra AJ; Saito K; Mouri A; Nabeshima T
J Neurochem; 2021 Jun; 157(6):1963-1978. PubMed ID: 33095942
[TBL] [Abstract][Full Text] [Related]
56. The IFN-γ-IDO1-kynureine pathway-induced autophagy in cervical cancer cell promotes phagocytosis of macrophage.
Yang SL; Tan HX; Niu TT; Liu YK; Gu CJ; Li DJ; Li MQ; Wang HY
Int J Biol Sci; 2021; 17(1):339-352. PubMed ID: 33390854
[No Abstract] [Full Text] [Related]
57. Population Pharmacokinetic and Pharmacodynamic Modeling of Epacadostat in Patients With Advanced Solid Malignancies.
Shi JG; Bowman KJ; Chen X; Maleski J; Leopold L; Yeleswaram S
J Clin Pharmacol; 2017 Jun; 57(6):720-729. PubMed ID: 27990653
[TBL] [Abstract][Full Text] [Related]
58. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors.
Naing A; Eder JP; Piha-Paul SA; Gimmi C; Hussey E; Zhang S; Hildebrand V; Hosagrahara V; Habermehl C; Moisan J; Papadopoulos KP
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32843490
[TBL] [Abstract][Full Text] [Related]
59. Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity.
Mondanelli G; Albini E; Orecchini E; Pallotta MT; Belladonna ML; Ricci G; Grohmann U; Orabona C
Front Immunol; 2021; 12():713989. PubMed ID: 34394118
[TBL] [Abstract][Full Text] [Related]
60. Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.
Souza LC; Jesse CR; de Gomes MG; Del Fabbro L; Goes ATR; Donato F; Boeira SP
Neurochem Res; 2017 Oct; 42(10):2982-2995. PubMed ID: 28631232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
